UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)

Cancer chemotherapy and pharmacology, 2020-07, Vol.86 (1), p.117-127

2020

Volltextzugriff (PDF)

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer

Oncoimmunology, 2021-01, Vol.10 (1), p.1971430-1971430

2021

Volltextzugriff (PDF)

Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A)

Lung cancer (Amsterdam, Netherlands), 2015-12, Vol.90 (3), p.548-553

2015

Volltextzugriff (PDF)

Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival

Heliyon, 2020-07, Vol.6 (7), p.e04439, Article e04439

2020

Volltextzugriff (PDF)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer

BMC cancer, 2007-03, Vol.7 (1), p.51-51, Article 51

2007

Volltextzugriff (PDF)

Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)

The oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.e1172-e1179

2019

Volltextzugriff (PDF)

Phase II Study of Carboplatin and Weekly Paclitaxel in Advanced Non-small Cell Lung Cancer

Anticancer research, 2006-09, Vol.26 (5B), p.3767-3772

2006

Volltextzugriff (PDF)

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.134-142

2021

Volltextzugriff (PDF)

Abstract 4029: Analysis of DLL3 and ASCL1 in surgically resected small cell lung cancer (HOT1702)

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4029-4029

2019

Volltextzugriff (PDF)

Expression of Notch1 and Numb in small cell lung cancer

Oncotarget, 2017-02, Vol.8 (6), p.10348-10358

2017

Volltextzugriff (PDF)

Abstract 4735: Expression of Notch1 and Numb in small cell lung cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4735-4735

2017

Volltextzugriff (PDF)

Clinical and molecular profiling of surgically resected small-cell lung cancer: Intergroup study with FIGHT002 and HOT1301

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7590-7590

2014

Volltextzugriff (PDF)

Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.745-757

2015

Volltextzugriff (PDF)

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125 I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

Lung cancer (Amsterdam, Netherlands), 2021-03, Vol.153, p.134

2021

Volltextzugriff (PDF)

Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

Oncology, 2011-10, Vol.81 (2), p.84-90

2011

Volltextzugriff (PDF)

Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancer

Cancer, 1995-12, Vol.76 (12), p.2457-2463

1995

Volltextzugriff (PDF)

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer

Cancer, 1995-12, Vol.76 (12), p.2457-2463

1995

Volltextzugriff (PDF)

Review of Early Lung Cancer Cases Treated by Our Hospital in Eastern Hokkaido

JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE, 1998/11/03, Vol.47(4), pp.596-601

1998

Volltextzugriff (PDF)

Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer

Cancer research (Chicago, Ill.), 1995-04, Vol.55 (7), p.1559-1564

1995

Volltextzugriff (PDF)

Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history

American journal of clinical pathology, 1994-11, Vol.102 (5), p.660-664

1994

Volltextzugriff (PDF)

Simultaneous use of the PCR-SSCP method and immunohistochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer

American journal of clinical pathology, 1995-09, Vol.104 (3), p.319-324

1995

Volltextzugriff (PDF)

Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer : Potential synergistic effect with altered p53 protein on proliferative activity

Cancer research (Chicago, Ill.), 1996-12, Vol.56 (24), p.5557-5562

1996

Volltextzugriff (PDF)

A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer

Antisense & nucleic acid drug development, 2000-08, Vol.10 (4), p.243-249

2000

Volltextzugriff (PDF)

Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode

Nature communications, 2020-08, Vol.11 (1), p.1-9, Article 4160

2020

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(91)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(111)
Tagungsberichte
(1)

Sprache

Englisch
(97)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)

Prognostic significance of OX40+ lymphocytes in tumor stroma of surgically resected small-cell lung cancer

Prognostic impact of clinical variables on surgically resected small-cell lung cancer: Results of a retrospective multicenter analysis (FIGHT002A and HOT1301A)

Detection of somatic TP53 mutation in surgically resected small-cell lung cancer by targeted exome sequencing: association with longer relapse-free survival

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer

Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)

Phase II Study of Carboplatin and Weekly Paclitaxel in Advanced Non-small Cell Lung Cancer

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

Abstract 4029: Analysis of DLL3 and ASCL1 in surgically resected small cell lung cancer (HOT1702)

Expression of Notch1 and Numb in small cell lung cancer

Abstract 4735: Expression of Notch1 and Numb in small cell lung cancer

Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker

Clinical and molecular profiling of surgically resected small-cell lung cancer: Intergroup study with FIGHT002 and HOT1301

Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients

Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125 I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)

Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancer

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer

Review of Early Lung Cancer Cases Treated by Our Hospital in Eastern Hokkaido

Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer

Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history

Simultaneous use of the PCR-SSCP method and immunohistochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer

Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer : Potential synergistic effect with altered p53 protein on proliferative activity

A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer

Structure of an antagonist-bound ghrelin receptor reveals possible ghrelin recognition mode

Suchergebnisse filtern